Go Pro

SBC Medical Group (SBC) Competitors

SBC Medical Group logo
$4.46 +0.06 (+1.36%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$4.46 0.00 (0.00%)
As of 09/11/2026 04:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SBC vs. AGL, INNV, OMDA, PNTG, and AMN

Should you buy SBC Medical Group stock or one of its competitors? SBC Medical Group's main competitors and comparable companies include Agilon Health (AGL), InnovAge (INNV), Omada Health (OMDA), The Pennant Group (PNTG), and AMN Healthcare Services (AMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does SBC Medical Group compare to Agilon Health?

Agilon Health (NYSE:AGL) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

Agilon Health presently has a consensus target price of $97.70, indicating a potential upside of 9.05%. SBC Medical Group has a consensus target price of $8.50, indicating a potential upside of 90.58%. Given SBC Medical Group's stronger consensus rating and higher probable upside, analysts plainly believe SBC Medical Group is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

SBC Medical Group has a net margin of 27.99% compared to Agilon Health's net margin of -3.92%. SBC Medical Group's return on equity of 18.47% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilon Health-3.92% -119.38% -16.85%
SBC Medical Group 27.99%18.47%13.10%

In the previous week, Agilon Health had 3 more articles in the media than SBC Medical Group. MarketBeat recorded 5 mentions for Agilon Health and 2 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.14 beat Agilon Health's score of 0.61 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilon Health
1 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SBC Medical Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SBC Medical Group has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilon Health$5.93B0.25-$391.35M-$14.27N/A
SBC Medical Group$173.61M2.64$50.99M$0.479.49

Agilon Health has a beta of 3.02, meaning that its share price is 202% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market.

60.8% of SBC Medical Group shares are owned by institutional investors. 2.5% of Agilon Health shares are owned by company insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

SBC Medical Group beats Agilon Health on 12 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to InnovAge?

SBC Medical Group (NASDAQ:SBC) and InnovAge (NASDAQ:INNV) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

60.8% of SBC Medical Group shares are owned by institutional investors. Comparatively, 12.3% of InnovAge shares are owned by institutional investors. 81.7% of SBC Medical Group shares are owned by insiders. Comparatively, 1.0% of InnovAge shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

SBC Medical Group has a net margin of 27.99% compared to InnovAge's net margin of -0.26%. SBC Medical Group's return on equity of 18.47% beat InnovAge's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group27.99% 18.47% 13.10%
InnovAge -0.26%-1.03%-0.47%

SBC Medical Group presently has a consensus target price of $8.50, suggesting a potential upside of 90.58%. InnovAge has a consensus target price of $10.50, suggesting a potential downside of 2.33%. Given SBC Medical Group's stronger consensus rating and higher possible upside, equities analysts plainly believe SBC Medical Group is more favorable than InnovAge.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
InnovAge
2 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.75

In the previous week, InnovAge had 20 more articles in the media than SBC Medical Group. MarketBeat recorded 22 mentions for InnovAge and 2 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.14 beat InnovAge's score of 0.19 indicating that SBC Medical Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SBC Medical Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
InnovAge
3 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

SBC Medical Group has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market. Comparatively, InnovAge has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market.

SBC Medical Group has higher earnings, but lower revenue than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M2.64$50.99M$0.479.49
InnovAge$989.71M1.48-$30.31M-$0.02N/A

Summary

SBC Medical Group beats InnovAge on 14 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to Omada Health?

SBC Medical Group (NASDAQ:SBC) and Omada Health (NASDAQ:OMDA) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability.

SBC Medical Group has a net margin of 27.99% compared to Omada Health's net margin of 1.39%. SBC Medical Group's return on equity of 18.47% beat Omada Health's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group27.99% 18.47% 13.10%
Omada Health 1.39%2.60%1.98%

SBC Medical Group presently has a consensus price target of $8.50, indicating a potential upside of 90.58%. Omada Health has a consensus price target of $26.67, indicating a potential upside of 35.64%. Given SBC Medical Group's higher possible upside, analysts plainly believe SBC Medical Group is more favorable than Omada Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Omada Health
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71

In the previous week, Omada Health had 14 more articles in the media than SBC Medical Group. MarketBeat recorded 16 mentions for Omada Health and 2 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.14 beat Omada Health's score of 0.49 indicating that SBC Medical Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SBC Medical Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Omada Health
3 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

SBC Medical Group has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market. Comparatively, Omada Health has a beta of 1.86, indicating that its stock price is 86% more volatile than the broader market.

60.8% of SBC Medical Group shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by company insiders. Comparatively, 6.4% of Omada Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

SBC Medical Group has higher earnings, but lower revenue than Omada Health. SBC Medical Group is trading at a lower price-to-earnings ratio than Omada Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M2.64$50.99M$0.479.49
Omada Health$309.76M3.89-$12.78M$0.05393.20

Summary

SBC Medical Group beats Omada Health on 9 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to The Pennant Group?

The Pennant Group (NASDAQ:PNTG) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation.

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are held by institutional investors. 6.9% of The Pennant Group shares are held by insiders. Comparatively, 81.7% of SBC Medical Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

SBC Medical Group has lower revenue, but higher earnings than The Pennant Group. SBC Medical Group is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$947.71M1.44$29.58M$0.9043.56
SBC Medical Group$173.61M2.64$50.99M$0.479.49

The Pennant Group has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market.

The Pennant Group currently has a consensus target price of $41.60, suggesting a potential upside of 6.12%. SBC Medical Group has a consensus target price of $8.50, suggesting a potential upside of 90.58%. Given SBC Medical Group's higher possible upside, analysts clearly believe SBC Medical Group is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

SBC Medical Group has a net margin of 27.99% compared to The Pennant Group's net margin of 2.93%. SBC Medical Group's return on equity of 18.47% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.93% 10.33% 4.20%
SBC Medical Group 27.99%18.47%13.10%

In the previous week, The Pennant Group had 1 more articles in the media than SBC Medical Group. MarketBeat recorded 3 mentions for The Pennant Group and 2 mentions for SBC Medical Group. The Pennant Group's average media sentiment score of 1.82 beat SBC Medical Group's score of 1.14 indicating that The Pennant Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
SBC Medical Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

The Pennant Group beats SBC Medical Group on 9 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to AMN Healthcare Services?

SBC Medical Group (NASDAQ:SBC) and AMN Healthcare Services (NYSE:AMN) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

SBC Medical Group has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

60.8% of SBC Medical Group shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

SBC Medical Group has higher earnings, but lower revenue than AMN Healthcare Services. SBC Medical Group is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M2.64$50.99M$0.479.49
AMN Healthcare Services$2.73B0.47-$95.70M$2.6812.44

In the previous week, AMN Healthcare Services had 1 more articles in the media than SBC Medical Group. MarketBeat recorded 3 mentions for AMN Healthcare Services and 2 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.14 beat AMN Healthcare Services' score of 0.92 indicating that SBC Medical Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SBC Medical Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SBC Medical Group presently has a consensus target price of $8.50, suggesting a potential upside of 90.58%. AMN Healthcare Services has a consensus target price of $36.00, suggesting a potential upside of 8.02%. Given SBC Medical Group's higher probable upside, equities research analysts clearly believe SBC Medical Group is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
AMN Healthcare Services
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38

SBC Medical Group has a net margin of 27.99% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat SBC Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group27.99% 18.47% 13.10%
AMN Healthcare Services 3.06%19.92%5.93%

Summary

SBC Medical Group and AMN Healthcare Services tied by winning 8 of the 16 factors compared between the two stocks.

Get SBC Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBC vs. The Competition

MetricSBC Medical GroupHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$458.70M$9.84B$7.17B$12.85B
Dividend YieldN/A2.61%2.57%11.71%
P/E Ratio9.4933.53274.9425.27
Price / Sales2.644.89633.2390.48
Price / Cash8.52125.1576.6551.52
Price / Book1.745.2910.336.20
Net Income$50.99M$313.25M$3.50B$358.50M
7 Day Performance8.25%-1.26%-3.32%-2.35%
1 Month Performance39.38%-0.98%-0.41%-2.77%
1 Year Performance-0.45%15.13%19.21%7.63%

SBC Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBC
SBC Medical Group
4.1884 of 5 stars
$4.46
+1.4%
$8.50
+90.6%
-0.7%$458.70M$173.61M9.49N/A
AGL
Agilon Health
1.3279 of 5 stars
$87.86
+0.4%
$97.70
+11.2%
+231.8%$1.48B$5.93BN/A1,076
INNV
InnovAge
0.9223 of 5 stars
$10.82
-0.1%
$10.00
-7.5%
+132.7%$1.47B$949.17MN/A2,440
OMDA
Omada Health
3.866 of 5 stars
$23.07
+1.0%
$26.50
+14.9%
-11.1%$1.41B$260.21M462.00849
PNTG
The Pennant Group
3.7159 of 5 stars
$37.87
+0.3%
$41.60
+9.9%
+52.5%$1.32B$1.10B42.139,700

Related Companies and Tools


This page (NASDAQ:SBC) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners